{
  "nctId": "NCT01921517",
  "briefTitle": "Micromechanical Modeling Using Low Magnitude Mechanical Stimulation",
  "officialTitle": "Osteoporosis Treatment Response Assessed by Micromechanical Modeling of MRI Data",
  "protocolDocument": {
    "nctId": "NCT01921517",
    "filename": "Prot_SAP_ICF_000.pdf",
    "label": "Study Protocol, Statistical Analysis Plan, and Informed Consent Form",
    "date": "2018-10-24",
    "uploadDate": "2019-09-19T11:16",
    "size": 378336,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT01921517/document/Prot_SAP_ICF_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": true
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "TRIPLE",
  "enrollmentInfo": {
    "enrollmentCount": 117,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2012-09",
    "completionDate": "2019-06-20",
    "primaryCompletionDate": "2019-02-28",
    "firstSubmitDate": "2013-08-08",
    "firstPostDate": "2013-08-13"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Females, ages 45-65 years and post menopausal, as defined by a history of amenorrhea for a minimum of 24 months and a serum FSH (follicle-stimulating hormone) concentration of 25 mIU/mL (milli-International unit per milliliter) and negative pregnancy test.\n\nExclusion Criteria:\n\n* Current or prior use of medications known to affect bone (e.g. bisphosphonates, calcitonin, selective estrogen receptor modulators, denosumab, diphenylhydantoin, recent systemic glucocorticoid use), bone mineral density T score of less than -2.5 and greater than +2, Vitamin D level less then 12 ng/ml, BMI (body mass index) of greater than 32, current alcohol or drug abuse: more than 3 alcoholic beverages per day or current abuse of illicit drugs or prescription medication, uncontrolled or untreated cardiac or pulmonary disease liver disease: history of hepatitis or ALT (alanine aminotransferase) or AST (aspartate aminotransferase) greater than 2x ULN (upper limit of normal), renal disease: history of renal disease or serum creatinine greater than 2x ULN diabetes, pacemaker or metallic implants considered a contraindication to MR scanning.",
    "healthyVolunteers": true,
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "maximumAge": "65 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in Distal Tibia Bone Quality",
        "description": "Distal tibial bone quality is measured through MRI by calculating the ratio between bone volume to total volume. A lower value would indicate osteoporotic (weaker) bone; a higher value would indicate healthy (normal) bone.",
        "timeFrame": "Baseline to 12 months"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 39,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:02.938Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}